Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_assertion description "[We also describe the recent development and validation of the most studied mucins (MUC1 and MUC16), ErbB-2 (Her2/neu) and folate binding protein as target-based immunotherapy of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_assertion evidence source_evidence_literature NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_assertion SIO_000772 14755889 NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_assertion wasDerivedFrom befree-20140225 NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_assertion wasGeneratedBy ECO_0000203 NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.
- befree-20140225 importedOn "2014-02-25" NP278767.RAJVSZWzVylcs0_l2_AYsFjfd2j0FrhY00iV6nhIhmU2g130_provenance.